RF-positive patients (n = 29) | RF-negative patients (n = 18) | P-value | |
---|---|---|---|
Initial dose of PSL, mg | 40 (30-50) | 30 (30-40) | 0.07 |
Immunosuppressive agent usage | |||
Induction therapy, no (%) | 10 (34) | 4 (22) | 0.52 |
IVCY, no (%) | 5 (17) | 0 (0) | 0.14 |
POCY, no (%) | 5 (17) | 3 (17) | 1 |
Maintenance therapy, no (%) | 12 (41) | 7 (39) | 1 |
Recurrence, no (%) | 3 (10) | 4 (22) | 0.40 |
Dialysis, no (%) | 4 (14) | 1 (6) | 0.64 |
Mechanical ventilation, no (%) | 4 (14) | 0 (0) | 0.28 |
Dead, no (%) | 3 (10) | 0 (0) | 0.28 |